Full-Time

Delivery Lead

Posted on 3/12/2025

Bupa

Bupa

10,001+ employees

Compensation Overview

£50k - £60kAnnually

+ 10% Bonus

Mid, Senior

Staines-upon-Thames, UK + 1 more

More locations: London, UK

The job can be performed from Manchester, Leeds, or Staines, indicating flexibility in location. However, it is not fully remote.

Category
Project Management
Business & Strategy
Required Skills
Agile
Risk Management
Requirements
  • Substantial experience in business and IT change
  • Results oriented and focused on adding value to Bupa
  • Strong stakeholder management skills across a wide range of different senior stakeholders
  • Ability to thrive in pressurised environments
  • Clear approach to decision making and tenacious approach to problem solving
  • Experienced in risk, resource, and cost/benefit management
  • Experience of multiple business and IT project delivery methodologies (e.g., MSP, Prince2, Agile, SDLC)
Responsibilities
  • Leadership of planning, shaping and management of change initiatives or workstreams in line with the identified delivery methodology
  • Create and manage optimised project plans, budgets, critical success factors and key milestones for all workstreams
  • Lead appropriate project and workstream teams, negotiating and influencing with resource managers
  • Encourage effective working relationships with colleagues across Bupa and third parties
  • Effectively engage and manage vendors, focusing on strong delivery capability and cost efficiency opportunities
  • Successfully coordinate the initiative and its dependencies, ensuring clear management and control of scope, budget and quality
  • Agree responsibilities clearly with individual delivery team members
Desired Qualifications
  • Prince 2 and Agile trained

Company Size

10,001+

Company Stage

Acquired

Total Funding

N/A

Headquarters

London, United Kingdom

Founded

1974

Simplify Jobs

Simplify's Take

What believers are saying

  • Bupa's 'My Genomic Health' pilot positions it as a leader in personalized healthcare.
  • Acquisition of London Medical expands Bupa's specialist outpatient services in premium healthcare.
  • Partnership with Nexer enhances digital accessibility, broadening appeal to diverse customers.

What critics are saying

  • Increased competition in genomics from expanding companies like Genomics.
  • Challenges in integrating The Dermatology Partnership may affect service delivery.
  • Uncertainty in the success of Bupa's whole genome sequencing pilot program.

What makes Bupa unique

  • Bupa is the first major UK private healthcare provider offering whole genome sequencing.
  • Bupa's acquisition of The Dermatology Partnership enhances its direct-to-consumer dermatology services.
  • Bupa's collaboration with Channel 4 supports accessibility post-Paris 2024 Paralympic Games.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Paid Vacation

Life Insurance

401(k) Retirement Plan

Performance Bonus

Gym Membership

Hybrid Work Options

Company News

PR Newswire
Jan 9th, 2025
J.P. Morgan Healthcare Conference 2025: Genomics Announces Dr Jose-Carlos Gutiérrez-Ramos As New Board Member To Accelerate Global Expansion And Life Sciences Rd Growth

Dr Jose-Carlos Gutiérrez- Ramos is the Chief Science Officer at Danaher Corporation. He has held senior drug discovery roles at Pfizer, Abbvie, and GSK. As CEO and President of Synlogic, he led the company from early drug discovery to clinical stage and public marketsHe brings a wealth of experience across biotechs and pharmaceutical companies, combined with deep expertise in science and tech for successful drug discovery, drug development programmes, and marketed drugsThe appointment strengthens the company's commercial capabilities, life sciences innovation, and R&D offering, to advance Genomics' mission of changing the future of healthcareOXFORD, England, Jan. 9, 2025 /PRNewswire/ -- Genomics , a healthcare company using large-scale genetic information to develop innovative precision healthcare tools and to bring new understanding to drug discovery, today announced the appointment of Dr Jose-Carlos Gutiérrez-Ramos to its Board. The appointment will support the company's rapid growth and strengthen its commercial offering globally, with a focus on scaling its life sciences business. The announcement coincides with significant Genomics presence at the J.P

LaingBuisson
Dec 2nd, 2024
Bupa acquires The Dermatology Partnership

Bupa Health Services has acquired The Dermatology Partnership (TDP) from August Equity to enhance its direct-to-consumer offerings. The financial details of the deal were not disclosed. This acquisition aims to reduce long waiting times for dermatology services in the UK, benefiting Bupa's UK Insurance customers.

Syenza
Oct 19th, 2024
Bupa Launches Whole Genome Sequencing Pilot in UK

Bupa has launched a two-year pilot program called "My Genomic Health," establishing itself as the first major private healthcare provider in the UK to offer whole genome sequencing to selected customers.

The Telegraph
Oct 16th, 2024
Patients will be told how to prevent genetic diseases in major trial

Bupa launches gene-mapping programme to tackle common disorders with tailored 'health plans'

Healthcare and Protection
Sep 6th, 2024
Bupa appoints acting MD for health insurance in Australia

Bupa has appointed Kate Williams as acting managing director of health insurance for Australia.